SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3.86 |
| Enterprise Value ($M) | -5.50 |
| Book Value ($M) | 17.81 |
| Book Value / Share | 14.07 |
| Price / Book | 0.22 |
| NCAV ($M) | 8.95 |
| NCAV / Share | 7.07 |
| Price / NCAV | 0.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.89 |
| Return on Assets (ROA) | -0.51 |
| Return on Equity (ROE) | -0.56 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 14.81 |
| Current Ratio | 14.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 9.78 |
| Assets | 18.64 |
| Liabilities | 0.82 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 6,288 | 19,969 | 31.49 | |
| 3,309 | 21,370 | 15.48 | |
| 1,368 | 17,159 | 7.97 | |
| 6,840 | 41,256 | 16.58 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KALA – KALA BIO, Inc. | KPRX – Kiora Pharmaceuticals, Inc. |
| KRRO – Korro Bio, Inc. | KZR – Kezar Life Sciences, Inc. |
| LEXX – Lexaria Bioscience Corp. |
Financial data and stock pages provided by
Fintel.io